Lung Cancer Clinical Trials in Philadelphia

Showing 661-680 of 687 trials

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

NCT00517595

The primary objective is to determine the progression free survival with pemetrexed, and gemcitabine plus bevacizumab as first-line chemotherapy in elderly patients with Stage IIIB/IV non-small cell lung cancer (NSCLC). The secondary objectives are to determine the overall response rate; overall survival; chemotherapy induced toxicity profile of this combination; time to progression; and patient reported symptom burden.

Non-Small Cell Lung Cancer

Accelerated Community Oncology Research Network48 participantsStarted Aug 2007

Waterbury, Connecticut, United States • Augusta, Georgia, United States • Macon, Georgia, United States +7 more locations

COMPLETEDPhase 2< 1 mile

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

NCT00343291

The primary objective of this study will be to determine the progression free survival of patients with stage IIIb/IV non-small cell lung cancer (NSCLC) treated with dual agent monoclonal antibody therapy consisting of cetuximab and bevacizumab in combination with two different regimens of paclitaxel and carboplatin chemotherapy.

Non-Small Cell Lung Cancer

Eli Lilly and Company121 participantsStarted Dec 2006

Decatur, Alabama, United States • Huntsville, Alabama, United States • Scottsdale, Arizona, United States +40 more locations

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Lung Cancer Trials in Other Cities

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Study of XL281 in Adults With Solid Tumors

Lung Cancer Informational Study (LCIS)

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Other Conditions in Philadelphia